These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27019103)

  • 1. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.
    Tamminga HG; Reneman L; Huizenga HM; Geurts HM
    Psychol Med; 2016 Jul; 46(9):1791-807. PubMed ID: 27019103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
    Idema IME; Payne JM; Coghill D
    J Consult Clin Psychol; 2021 Jul; 89(7):615-625. PubMed ID: 34383534
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder.
    Kubas HA; Backenson EM; Wilcox G; Piercy JC; Hale JB
    Postgrad Med; 2012 Sep; 124(5):33-48. PubMed ID: 23095424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
    Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
    Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD.
    Tamminga HGH; Reneman L; Schrantee A; Bottelier MA; Bouziane C; Geurts HM; Groenman AP
    Eur Neuropsychopharmacol; 2021 May; 46():1-13. PubMed ID: 33735707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM; Bralten J; An L; Cao QJ; Cao XH; Sun L; Liu L; Yang L; Mennes M; Zang YF; Franke B; Hoogman M; Wang YF
    J Psychopharmacol; 2017 Aug; 31(8):1061-1069. PubMed ID: 28656805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan.
    Takahashi N; Koh T; Tominaga Y; Saito Y; Kashimoto Y; Matsumura T
    World J Biol Psychiatry; 2014 Aug; 15(6):488-98. PubMed ID: 24456065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder.
    Prehn-Kristensen A; Krauel K; Hinrichs H; Fischer J; Malecki U; Schuetze H; Wolff S; Jansen O; Duezel E; Baving L
    Brain Res; 2011 May; 1388():56-68. PubMed ID: 21385569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.
    Coghill DR; Seth S; Pedroso S; Usala T; Currie J; Gagliano A
    Biol Psychiatry; 2014 Oct; 76(8):603-15. PubMed ID: 24231201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
    Pearson DA; Santos CW; Casat CD; Lane DM; Jerger SW; Roache JD; Loveland KA; Lachar D; Faria LP; Payne CD; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):677-85. PubMed ID: 15167084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder.
    Bedard AC; Martinussen R; Ickowicz A; Tannock R
    J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):260-8. PubMed ID: 15076258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.
    Rosch KS; Fosco WD; Pelham WE; Waxmonsky JG; Bubnik MG; Hawk LW
    J Abnorm Child Psychol; 2016 Feb; 44(2):309-21. PubMed ID: 25985978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylphenidate on complex cognitive processing in attention-deficit hyperactivity disorder.
    Berman T; Douglas VI; Barr RG
    J Abnorm Psychol; 1999 Feb; 108(1):90-105. PubMed ID: 10066996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential long-term medication impact on executive function and delay aversion in ADHD.
    Rubio Morell B; Hernández Expósito S
    Appl Neuropsychol Child; 2019; 8(2):140-157. PubMed ID: 29244542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.